Mwg Management Ltd. Vir Biotechnology, Inc. Transaction History

Mwg Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$34.9 - $54.54 $2.61 Million - $4.08 Million	-74,743 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$38.75 - $51.0 $9.7 Million - $12.8 Million	-250,257 Reduced 77.0%	74,743 $3.53 Million
Q1 2021 May 17, 2021	BUY	$26.34 - $83.07 $8.55 Million - $27 Million	324,675 Added 99900.0%	325,000 $16.7 Million
Q4 2020 Feb 17, 2021	BUY	$25.51 - $43.38 $8,290 - $14,098	325 New	325 $8.7 Million

232

87.6M

231K

132K

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.03B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Mwg Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Mwg Management Ltd. with notifications on news.